Gyon Technologies Capital Management, LP Immuno Gen, Inc. Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $65,620 - $91,002	14,422 Added 123.74%	26,077 $129,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $52,214 - $75,407	11,655 New	11,655 $56,000
Q1 2022 May 12, 2022	SELL	$4.26 - $7.48 $192,539 - $338,073	-45,197 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $214,685 - $338,977	45,197 New	45,197 $335,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.